Olaparib targets Ubiquitin D to promote autophagy in hepatocellular carcinoma by regulating glutamine metabolism

Authors

Institutions

Publication Details

Journal
Expert Review of Anticancer Therapy
Published
2025-11-06
DOI
https://doi.org/10.1080/14737140.2025.2586736
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Olaparib targets Ubiquitin D to promote autophagy in hepatocellular carcinoma by regulating glutamine metabolism

Haiyan Qu, Ningjun Li, Xi Chen, Fangfang Zhang et al.
Expert Review of Anticancer Therapy
PARP inhibition in cancer therapy
article

Olaparib targets Ubiquitin D to promote autophagy in hepatocellular carcinoma by regulating glutamine metabolism

Haiyan Qu, Ningjun Li, Xi Chen, Fangfang Zhang, Wenhui Tu, Weijun Zhu
article en

Abstract

No abstract available for this paper.
Expert Review of Anticancer TherapyVol. 26(3)
Taizhou Municipal Hospital (CN), Taizhou University (CN)
Openalex Percentile: Top 55%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.